Oliver Hoffmann

2.6k citations

81 papers · 1.7k indexed · h-index 22

Impact in

Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Oncology top 5%
- Cancer Cells and Metastasis

Papers in ⓘ

Cancer Research 28
- Breast Cancer Treatment Studies 12
- Cancer Genomics and Diagnostics 11
Oncology 41
- Cancer Cells and Metastasis 17
- HER2/EGFR in Cancer Research 9

Co-authors: Rainer Kimmig (36 shared papers)Sabine Kasimir‐Bauer (29 shared papers)Tanja Fehm (8 shared papers)D. Wallwiener (6 shared papers)Ann‐Kathrin Bittner (31 shared papers)Bahriye Aktas (3 shared papers)Lisa König (4 shared papers)Lale Umutlu (16 shared papers)
Journals: Cancers (8 papers)Cancer Research (6 papers)Archives of Gynecology and Obstetrics (4 papers)Journal of Clinical Oncology (4 papers)ESMO Open (3 papers)
Partner nations: Germany United States Switzerland

In The Last Decade

Oliver Hoffmann

79 papers receiving 1.7k citations

Peers

Countries citing papers authored by Oliver Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Oliver Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Hoffmann more than expected).

Fields of papers citing papers by Oliver Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Hoffmann. The network helps show where Oliver Hoffmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Oliver Hoffmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Oliver Hoffmann Line = papers co-authored together Oliver Hoffmann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 81 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells Breast Cancer Research ·Sabine Kasimir‐Bauer, Oliver Hoffmann, D. Wallwiener, Rainer Kimmig, Tanja Fehm	2012	241
2	Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells Breast Cancer Research ·Tanja Fehm, Oliver Hoffmann, Bahriye Aktas, Sven Becker, Erich Solomayer, D. Wallwiener, Rainer Kimmig, Sabine Kasimir‐Bauer	2009	193
3	Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy OncoImmunology ·Lisa König, Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, Oliver Hoffmann, Bettina Wagner, Luis Felipe Santos Manvailer, Rainer Kimmig, Peter A. Horn, Vera Rebmann	2017	99
4	Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer Investigative Radiology ·Johannes Grueneisen, James Nagarajah, Christian Buchbender, Oliver Hoffmann, Benedikt M. Schaarschmidt, Thorsten D. Poeppel, Michael Forsting, Harald H. Quick, Lale Umutlu, Sonja Kinner	2015	71
5	The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients Human Immunology ·Lisa König, Sabine Kasimir‐Bauer, Oliver Hoffmann, Ann‐Kathrin Bittner, Bettina Wagner, Luis Felipe Santos Manvailer, Sabine Schramm, Ágnes Bánkfalvi, Bernd Giebel, Rainer Kimmig, Peter A. Horn, Vera Rebmann	2016	69
6	Does primary neoadjuvant systemic therapy eradicate minimal residual disease? Analysis of disseminated and circulating tumor cells before and after therapy Breast Cancer Research ·Sabine Kasimir‐Bauer, Ann‐Kathrin Bittner, Lisa König, Katharina Reiter, Thomas Keller, Rainer Kimmig, Oliver Hoffmann	2016	66
7	Prognostic relevance of the HER2 status of circulating tumor cells in metastatic breast cancer patients screened for participation in the DETECT study program ESMO Open ·Volkmar Müller, Maggie Banys‐Paluchowski, Thomas W. P. Friedl, Peter A. Fasching, Andreas Schneeweiß, Andreas D. Hartkopf, D. Wallwiener, Brigitte Rack, F Meier-Stiegen, Jens Huober, Matthias Rübner, Oliver Hoffmann, L. Müller, Wolfgang Janni, Pauline Wimberger, Bernadette Jäger, Klaus Pantel, Sabine Riethdorf, Nadia Harbeck, Tanja Fehm	2021	45
8	Comparison of nodal staging between CT, MRI, and [18F]-FDG PET/MRI in patients with newly diagnosed breast cancer European Journal of Nuclear Medicine and Molecular Imaging ·Janna Morawitz, Nils Martin Bruckmann, Frederic Dietzel, T. Ullrich, Ann‐Kathrin Bittner, Oliver Hoffmann, Eugen Ruckhäberle, Svjetlana Mohrmann, Lena Häberle, Marc Ingenwerth, Daniel B. Abrar, Lino M. Sawicki, Katharina Breuckmann, Wolfgang P. Fendler, Ken Herrmann, Christian Buchbender, Gerald Antoch, Lale Umutlu, Julian Kirchner	2021	39
9	A rapid volume of interest-based approach of radiomics analysis of breast MRI for tumor decoding and phenotyping of breast cancer PLoS ONE ·Aydın Demircioğlu, Johannes Grueneisen, Marc Ingenwerth, Oliver Hoffmann, Katja Pinker, Elizabeth A. Morris, Johannes Haubold, Michael Forsting, Felix Nensa, Lale Umutlu	2020	37
10	Multiparametric Integrated 18F-FDG PET/MRI-Based Radiomics for Breast Cancer Phenotyping and Tumor Decoding Cancers ·Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, Janna Morawitz, Gerald Antoch, Marc Ingenwerth, Ann‐Kathrin Bittner, Oliver Hoffmann, Johannes Haubold, Johannes Grueneisen, Harald H. Quick, Christoph Rischpler, Ken Herrmann, Peter Gibbs, Katja Pinker	2021	37
11	Prospective comparison of the diagnostic accuracy of 18F-FDG PET/MRI, MRI, CT, and bone scintigraphy for the detection of bone metastases in the initial staging of primary breast cancer patients European Radiology ·Nils Martin Bruckmann, Julian Kirchner, Lale Umutlu, Wolfgang P. Fendler, Robert Seifert, Ken Herrmann, Ann‐Kathrin Bittner, Oliver Hoffmann, Svjetlana Mohrmann, Christina Antke, Lars Schimmöller, Marc Ingenwerth, Katharina Breuckmann, Andreas Stang, Christian Buchbender, Gerald Antoch, Lino M. Sawicki	2021	35
12	Integrative statistical analyses of multiple liquid biopsy analytes in metastatic breast cancer Genome Medicine ·Corinna Keup, Vinay Suryaprakash, Siegfried Hauch, Markus Storbeck, Peter F. Hahn, Markus Sprenger‐Haussels, Hans‐Christian Kolberg, Mitra Tewes, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir‐Bauer	2021	34
13	Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer BMC Cancer ·Lisa König, Fabian Mairinger, Oliver Hoffmann, Ann‐Kathrin Bittner, Kurt Werner Schmid, Rainer Kimmig, Sabine Kasimir‐Bauer, Ágnes Bánkfalvi	2019	34
14	Multiparametric 18F-FDG PET/MRI-Based Radiomics for Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Cancers ·Lale Umutlu, Julian Kirchner, Nils Martin Bruckmann, Janna Morawitz, Gerald Antoch, Saskia Ting, Ann‐Kathrin Bittner, Oliver Hoffmann, Lena Häberle, Eugen Ruckhäberle, Onofrio A. Catalano, Michal Chodyla, Johannes Grueneisen, Harald H. Quick, Wolfgang P. Fendler, Christoph Rischpler, Ken Herrmann, Peter Gibbs, Katja Pinker	2022	31
15	Zinc distribution within breast cancer tissue of different intrinsic subtypes Archives of Gynecology and Obstetrics ·P Rüsch, Alfred V. Hirner, Oliver J. Schmitz, Rainer Kimmig, Oliver Hoffmann, Maxim Diel	2020	30
16	Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer Clinical Cancer Research ·Tilman D. Rachner, Sabine Kasimir‐Bauer, Andy Göbel, Kati Erdmann, Oliver Hoffmann, Andrew Browne, Pauline Wimberger, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann‐Kathrin Bittner	2018	29
17	Effect of ibandronate on disseminated tumor cells in the bone marrow of patients with primary breast cancer: a pilot study. PubMed ·Oliver Hoffmann, Bahriye Aktas, Cornelia Goldnau, Martin Heubner, C. Oberhoff, Rainer Kimmig, Sabine Kasimir‐Bauer	2011	29
18	Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI European Journal of Nuclear Medicine and Molecular Imaging ·Julian Kirchner, Johannes Grueneisen, Ole Martin, Mark Oehmigen, Harald H. Quick, Ann‐Kathrin Bittner, Oliver Hoffmann, Marc Ingenwerth, Onofrio A. Catalano, Philipp Heusch, Christian Buchbender, Michael Forsting, Gerald Antoch, Ken Herrmann, Lale Umutlu	2018	27
19	Longitudinal Multi-Parametric Liquid Biopsy Approach Identifies Unique Features of Circulating Tumor Cell, Extracellular Vesicle, and Cell-Free DNA Characterization for Disease Monitoring in Metastatic Breast Cancer Patients Cells ·Corinna Keup, Vinay Suryaprakash, Markus Storbeck, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir‐Bauer	2021	27
20	Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer Journal of Cancer Research and Clinical Oncology ·Tilman D. Rachner, Sabine Kasimir‐Bauer, A Goebel, Kati Erdmann, Oliver Hoffmann, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann‐Kathrin Bittner	2021	24

About Oliver Hoffmann

Oliver Hoffmann is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Genetics, having authored 81 papers that have together received 1.7k indexed citations. Recurring topics across this work include Medical Imaging Techniques and Applications (19 papers), Cancer Cells and Metastasis (17 papers), Radiomics and Machine Learning in Medical Imaging (16 papers), Breast Cancer Treatment Studies (12 papers), Cancer Genomics and Diagnostics (11 papers), Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (9 papers) and MRI in cancer diagnosis (9 papers). The work is most often cited by research in Cancer Research (716 citations), Oncology (888 citations), Radiology, Nuclear Medicine and Imaging (383 citations), Pulmonary and Respiratory Medicine (330 citations) and Immunology (165 citations). Oliver Hoffmann has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Rainer Kimmig, Sabine Kasimir‐Bauer, Tanja Fehm, D. Wallwiener, Ann‐Kathrin Bittner, Bahriye Aktas, Lisa König, Lale Umutlu, Erich Solomayer and Sven Becker. Their work appears in journals such as Cancers, Cancer Research, Archives of Gynecology and Obstetrics, Journal of Clinical Oncology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact